Centocor Ortho Biotech v. Abbott Labs & NYU

CAFC Decision Overturning $1.6 Billion Verdict

more+
less-

Despite jury award of $1.6 Billion in damages, the CAFC held the patent invalid for failure to have satisfied the "written description" requirement that would have demonstrated that the inventors had "possession" of the biotech invention claimed, at the time he invenition was made.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Intellectual Property Updates

Reference Info:Decision | Federal, Federal Circuit, Patent | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Gerry Elman | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »